Literature DB >> 2529410

Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism.

C Gianoulakis1, D Béliveau, P Angelogianni, M Meaney, J Thavundayil, V Tawar, M Dumas.   

Abstract

The purpose of the present studies was to investigate the activity of the adrenal gland and the pituitary beta-endorphin system in individuals from families with a 3 generation history of alcoholism, High Risk group, or from families without history of alcoholism, Low Risk group. All subjects had a medical examination, a drinking behavior personal interview and the Michigan Alcoholism Screening Test. Individuals with medical problems or excessive drinking were not included in the study. On the day of testing, a blood sample was taken at 9:00 a.m., then the subject drank a placebo drink or an ethanol solution (0.5 g ethanol/kg B.Wt.). Additional blood samples were taken at 15, 45 and 120 minutes post-drink. Results indicated that individuals of the High Risk group had lower basal levels of beta-endorphin like immunoreactivity (beta-EPLIR) than individuals of the Low Risk group. The dose of 0.5 g ethanol/kg B.Wt. induced an increase in the plasma content of beta-EPLIR of the High Risk group, but not of the Low Risk group. In the Low Risk group ethanol did not induce an increase above the 9:00 a.m. levels, however, it attenuated the beta-endorphin decrease overtime, observed following the placebo drink. Analysis of beta-endorphin-like peptides in the plasma of the High Risk group, with Sephadex G-75 chromatography indicated that the major component of the plasma beta-EPLIR was beta-lipotropin. Plasma cortisol levels, following ethanol intake, presented a small increase in the High Risk group but not in the Low Risk group. Both groups presented similar blood alcohol levels. The basal levels of immunoreactive cortisol and beta-endorphin in the plasma of individuals who were alcoholics, but had been abstinent for at least six months prior to testing were similar to the levels of the High Risk group. Thus there are differences both in the basal levels and in the response of the cortisol and the pituitary beta-endorphin system to an acute ethanol challenge between the two groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529410     DOI: 10.1016/0024-3205(89)90167-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  25 in total

Review 1.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  Interaction between family history of alcoholism and Locus of Control in the opioid regulation of impulsive responding under the influence of alcohol.

Authors:  Lee J Altamirano; Howard L Fields; Mark D'Esposito; Charlotte A Boettiger
Journal:  Alcohol Clin Exp Res       Date:  2011-05-13       Impact factor: 3.455

3.  Beta-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice.

Authors:  Elizabeth T Barfield; Sarah M Barry; Hali B Hodgin; Brittany M Thompson; Stephani S Allen; Judith E Grisel
Journal:  Alcohol Clin Exp Res       Date:  2010-04-09       Impact factor: 3.455

Review 4.  The opioidergic-alcohol link : implications for treatment.

Authors:  Vania Modesto-Lowe; Eleanor M Fritz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study.

Authors:  Andrea C King; Patrick J McNamara; Deborah S Hasin; Dingcai Cao
Journal:  Biol Psychiatry       Date:  2013-10-02       Impact factor: 13.382

6.  Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.

Authors:  Jadwiga Zalewska-Kaszubska; Bartosz Bajer; Dorota Gorska; Dariusz Andrzejczak; Wanda Dyr; Przemysław Bieńkowski
Journal:  Psychopharmacology (Berl)       Date:  2012-07-31       Impact factor: 4.530

7.  Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

Authors:  James C Garbutt; Michael Osborne; Robert Gallop; John Barkenbus; Kathy Grace; Meghan Cody; Barbara Flannery; Alexey B Kampov-Polevoy
Journal:  Alcohol Alcohol       Date:  2009-02-03       Impact factor: 2.826

8.  Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys.

Authors:  M Kornet; C Goosen; J M Van Ree
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 9.  Endogenous opioids and excessive alcohol consumption.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

10.  The role of endogenous beta-endorphin and enkephalins in ethanol reward.

Authors:  Andy Tseng; Khanh Nguyen; Abdul Hamid; Mayank Garg; Paul Marquez; Kabirullah Lutfy
Journal:  Neuropharmacology       Date:  2013-06-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.